McKesson Corporation

McKesson Corporation

MCK Stock Report Card





Score: 100/100


MCK returned 22.17% in the last 12 months. Based on the other stocks in its sector with an average return of -4.76%, its performance is above average giving it a grade of 100 of 100.


Score: 57/100


14 analysts offer 12-month price forecasts for MCK. Together, they have an average target of 327.17, the most optimistic forecast put MCK at 426 within 12-months and the most pessimistic has MCK at 257.


Score: 64/100


MCK receives a 64 of 100 based on 14 indicators. 8 are bullish, 4 are bearish.


Score: 49/100


MCK has missed earnings 2 times in the last 20 quarters.


Score: 59/100


Out of the last 20 quarters, MCK has had 15 profitable quarters and has increased their profits year over year on 6 of them.


Score: 54/100


MCK has had a higher than average amount of volatility over the last 12 months giving it a grade of 54 of 100.


Score: 10/100


MCK's most recent dividend was $0.35 per share, based on a share price of $389.23. It was a payout ratio of -51.45% compared to their total earnings.

McKesson Corporation Summary

New York Stock Exchange / MCK
Medical Distribution
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
pluto logo
Los Angeles, CA

Pluto is not a broker-dealer, investment adviser or member of FINRA. Securities offered by Alpaca Securities LLC (“Alpaca Securities”). Alpaca Securities is a member of FINRA and the Securities Investor Protection Corporation.

Alpaca Securities, LLC (“Alpaca Securities”) is not responsible for and is not providing the technology and services you receive from us to access and manage your brokerage account with Alpaca Securities. You firmly agree to hold Alpaca and its affiliates, owners, directors, employees, clearing firm and agents harmless for any loss or damage arising from the use of or unavailability of the technology and services that we are providing.

The content on this website is for informational purposes only. Pluto does not recommend any specific securities or investment strategies. Investing involves risk & investments may lose value, including the loss of principal. Past performance does not guarantee future results. Investors should consider their investment objectives and risks carefully before investing.